BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cillo U, Vitale A, Navaglia F, Basso D, Montin U, Bassanello M, D’Amico F, Ciarleglio FA, Brolese A, Zanus G, Pascale VD, Plebani M, D’Amico DF. Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(44): 6920-6925 [PMID: 16437593 DOI: 10.3748/wjg.v11.i44.6920]
URL: https://www.wjgnet.com/1007-9327/full/v11/i44/6920.htm
Number Citing Articles
1
Alessandro Vitale, Filippo Navaglia, Rafael Ramírez Morales, Anna Chiara Frigo, Daniela Basso, Francesco D'Amico, Giacomo Zanus, Pasquale Bonsignore, Fabio Farinati, Patrizia Burra, Marco Senzolo, Francesco Grigoletto, Mario Plebani, Umberto Cillo, John D. Minna. Molecular Refinement of Clinical Staging in Hepatocellular Carcinoma Patients Evaluated for Potentially Curative TherapiesPLoS ONE 2011; 6(9): e23093 doi: 10.1371/journal.pone.0023093
2
Quirino Lai, Fabio Melandro, Rafael S. Pinheiro, Andrea Donfrancesco, Bashir A. Fadel, Giovanni B. Levi Sandri, Massimo Rossi, Pasquale B. Berloco, Fabrizio M. Frattaroli. Alpha-Fetoprotein and Novel Tumor Biomarkers as Predictors of Hepatocellular Carcinoma Recurrence after Surgery: A Brilliant Star Raises AgainInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/893103
3
Chee‐Chien Yong, Ming‐Chao Tsai, Chih‐Che Lin, Chih‐Chi Wang, Sheng‐Nan Lu, Chao‐Hung Hung, Tsung‐Hui Hu, Chao‐Long Chen. Comparison of Salvage Living Donor Liver Transplantation and Local Regional Therapy for Recurrent Hepatocellular CarcinomaWorld Journal of Surgery 2016; 40(10): 2472 doi: 10.1007/s00268-016-3559-1
4
Umberto Cillo, Tommaso Giuliani, Marina Polacco, Luz Maria Herrero Manley, Gino Crivellari, Alessandro Vitale. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationWorld Journal of Gastroenterology 2016; 22(1): 232-252 doi: 10.3748/wjg.v22.i1.232
5
Wei-long Zou, Yun-jin Zang, Xin-guo Chen, Zhong-yang Shen. Risk factors for fatal recurrence of liver transplant recipients with hepatocellular carcinoma in the first yearChinese Journal of Cancer Research 2007; 19(3): 165 doi: 10.1007/s11670-007-0165-7
6
Parissa Tabrizian, Myron E. Schwartz. Surgical Management of Hepatocellular CarcinomaMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 2012; 79(2): 223 doi: 10.1002/msj.21307
7
Clifford S. Cho. Prognostication Systems as Applied to Primary and Metastatic Hepatic MalignanciesSurgical Oncology Clinics of North America 2015; 24(1): 41 doi: 10.1016/j.soc.2014.09.010
8
Norman Kneteman, Tito Livraghi, David Madoff, Eduardo de Santibañez, Michael Kew. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantationLiver Transplantation 2011; 17(S2): S117 doi: 10.1002/lt.22334
9
Fabio Farinati, Anna Giacomin, Veronica Vanin, Adriana Sergio, Patrizia Burra, Umberto Cillo, Annamaria Di Nolfo, Paolo Del Poggio, Luisa Benvegnu, Marco Zoli, Franco Borzio, Edoardo G. Giannini, Eugenio Caturelli, Nora Cazzagon, Gian Ludovico Rapaccini, Franco Trevisani. Liver transplantation for hepatocellular carcinoma in clinical practiceEuropean Journal of Gastroenterology & Hepatology 2012; 24(2): 195 doi: 10.1097/MEG.0b013e32834e153c
10
L.M. Kulik, R.A. Fisher, D.R. Rodrigo, R.S. Brown, C.E. Freise, A. Shaked, J.E. Everhart, G.T. Everson, J.C. Hong, P.H. Hayashi, C.L. Berg, A.S.F. Lok. Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL CohortAmerican Journal of Transplantation 2012; 12(11): 2997 doi: 10.1111/j.1600-6143.2012.04272.x
11
Jinhui Zhu, Kai Yu, Ramon Andrade de Mello. International Manual of Oncology Practice2015; : 327 doi: 10.1007/978-3-319-21683-6_16
12
A. Kornberg, M. Freesmeyer, E. Bärthel, K. Jandt, K. Katenkamp, J. Steenbeck, A. Sappler, O. Habrecht, D. Gottschild. 18F-FDG-Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant PatientsAmerican Journal of Transplantation 2009; 9(3): 592 doi: 10.1111/j.1600-6143.2008.02516.x
13
Li-Ying Wang, Shu-Sen Zheng, Xiao Xu, Wei-Lin Wang, Jian Wu, Min Zhang, Yan Shen, Sheng Yan, Hai-Yang Xie, Xin-Hua Chen, Tian-An Jiang, Fen Chen. A score model for predicting post-liver transplantation survival in HBV cirrhosis-related hepatocellular carcinoma recipients: a single center 5-year experienceHepatobiliary & Pancreatic Diseases International 2015; 14(1): 43 doi: 10.1016/S1499-3872(15)60335-6
14
Quirino Lai, Alfonso W. Avolio, Tommaso M. Manzia, Salvatore Agnes, Giuseppe Tisone, Pasquale B. Berloco, Massimo Rossi. Role of Alpha-Fetoprotein in Selection of Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation: Must we Reconsider it?The International Journal of Biological Markers 2011; 26(3): 153 doi: 10.5301/JBM.2011.8557
15
Quirino Lai, Alfonso W. Avolio, Tommaso M. Manzia, Roberto Sorge, Salvatore Agnes, Giuseppe Tisone, Pasquale B. Berloco, Massimo Rossi. Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantationClinical Transplantation 2012; 26(2) doi: 10.1111/j.1399-0012.2011.01572.x
16
Hyung Soon Lee, Joon Ye Kim, Simon Weonsang Ro, Myoung Soo Kim, Haeryoung Kim, Dong Jin Joo. Antitumor Effect of Low-Dose of Rapamycin in a Transgenic Mouse Model of Liver CancerYonsei Medical Journal 2022; 63(11): 1007 doi: 10.3349/ymj.2022.0247